Arkuda Therapeutics
arkudatx.comArkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. Arkuda’s lead compounds aim to correct progranulin deficiency and lysosomal dysfunction in GRN-related frontotemporal dementia (FTD-GRN), a genetically-defined subtype of frontotemporal dementia caused by an autosomal dominant mutation in the GRN gene.
Something looks off?Open jobs at Arkuda Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.